(Q24564755)

6

0 references

author name string

Yifan Zhang

1

0 references

Xiaoyan Chen

3

0 references

Nan Lin

4

0 references

Yingjie Guo

5

0 references

Dafang Zhong

British Journal of Clinical Pharmacology

7

0 references

language of work or name

English

0 references

publication date

July 2007

0 references

published in

0 references

volume

64

0 references

issue

1

0 references

page(s)

67-74

0 references

cites work

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000619

Role of CYP2C9 and its variants (CYP2C9*3 and CYP2C9*13) in the metabolism of lornoxicam in humans

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000619

Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000619

Clinical significance of the cytochrome P450 2C19 genetic polymorphism

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000619

Gliclazide hydroxylation by rat liver microsomes

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000619

Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000619

Allele and genotype frequencies of CYP2C9 in a Korean population

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000619

Lornoxicam pharmacokinetics in relation to cytochrome P450 2C9 genotype

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000619

Gliclazide modified release: A critical review of pharmacodynamic, metabolic, and vasoprotective effects

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000619

Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000619

Gliclazide modified release

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000619

Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000619

Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000619

Identification of a novel variant CYP2C9 allele in Chinese

30 May 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.02846.X

Catalytic activities of human cytochrome P450 2C9*1, 2C9*3 and 2C9*13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.02846.X

Complete bioavailability and lack of food-effect on pharmacokinetics of gliclazide 30 mg modified release in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.02846.X

CYP2C9, but not CYP2C19, polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.02846.X

Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.02846.X

S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among Ethiopians

21 January 2018

2 references

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.02846.X

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000619

Four novel defective alleles and comprehensive haplotype analysis of CYP2C9 in Japanese.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000619

In vivo modulation of CYP enzymes by quinidine and rifampin

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17298483

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17298483

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Synthesis of putative metabolites and investigation of the metabolic fate of gliclazide, [1-(3-azabicyclo(3,3,0)oct-3-yl)-3-(4-methylphenylsulfonyl) urea], in diabetic patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17298483

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.2007.02846.X

1 reference

845364

845364

1 reference

1 reference

1 reference